| Authors: |
Grohar PJ; Division of Pediatric Hematology/Oncology, University of Michigan Medical School, C.S. Mott Children's Hospital, Rogel Cancer Center, Ann Arbor, MI, USA. grohar@med.umich.edu., Heise R; Weill Cornell Medicine, New York, NY, USA., Wedekind MF; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ballman K; Mayo Clinic, Rochester, MN, USA., Mascarenhas L; Guerin Children's and Cedars Sinai Cancer, Cedars Sinai Health Sciences University, Los Angeles, CA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA., Maki RG; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Boguslawski EA; Division of Pediatric Hematology/Oncology, University of Michigan Medical School, C.S. Mott Children's Hospital, Rogel Cancer Center, Ann Arbor, MI, USA., Gedminas JM; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Iowa, Iowa City, IA, USA., Wilson ER; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Thomas E; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Segers B; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Surrey LF; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Ricker C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA., Navid F; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Lam GY; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., The S; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Kaufman R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Roberts RD; Department of Pediatrics, Center for Childhood Cancer, Nationwide Children's Hospital, Ohio State University, Columbus, OH, USA., Hayashi M; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital of Colorado, Aurora, CO, USA., Mena E; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Overman L; Sarcoma Alliance for Research through Collaboration, Ann Arbor, MI, USA., Peer C; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schmidt K; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Diamond MS; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bagatell R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Liza Lindenberg M; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Choyke PL; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA., Widemann BC; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Glod JW; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Laetsch TW; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Reinke DK; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Chugh R; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA. |
